the therapeutic efficacy of oral n-acetylcysteine ( nac ) and ambroxol as compared with the effect of placebos was studied in 36 cystic fibrosis ( cf ) patients with mild to moderate pulmonary disease .
C0001047
n-acetylcysteine
C0010674
cystic fibrosis